ALNYLAM PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": -296008000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2015-01-01 – 2015-12-31 |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6313307c-de08-45c8-9de3-9202f3d06990
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-16-462538Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/operating-income/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6313307c-de08-45c8-9de3-9202f3d06990
History
- no predecessors — first report